FDA pol­i­cy change opens the door for abor­tion pill in phar­ma­cies

The FDA will now al­low cer­tain phar­ma­cies to dis­pense mifepri­s­tone, a pill used in com­bi­na­tion with an­oth­er med­i­cine, to end ear­ly preg­nan­cies.

Af­ter con­duct­ing a “com­pre­hen­sive re­view” of mifepri­s­tone’s risk eval­u­a­tion and mit­i­ga­tion strat­e­gy (REMS) — which pre­vi­ous­ly re­quired pa­tients to re­ceive the drug in a clin­ic, med­ical of­fice or hos­pi­tal — the agency on Tues­day ap­proved a mod­i­fi­ca­tion that per­mits cer­ti­fied phar­ma­cies to sell Dan­co Lab’s brand-name Mifeprex pills and a gener­ic man­u­fac­tured by Gen­Bio­Pro.

To read Endpoints News become a free subscriber

Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters

SIGN UP LOG IN